CVS Health Corporation (CVS)
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Under New CEO, Don't Look For Major CVS Health Breakup
The new chief executive officer of CVS Health is schooled in many of the traditions that built the company into a major player in both health insurance and healthcare delivery. So don't look for David Joyner to move away from vertical integration as both a provider and a health insurance company.
CVS workers strike at 7 California locations seeking better pay, health care
Workers at seven CVS pharmacies in California are now on strike, seeking better pay and health care, as the stores remain open and staffed by managers and nonunion employees.
2 "Safe" Healthcare Stocks That Are Anything But
If you buy these stocks, you might be in for serious disappointment when they underperform.
CVS Stock Plummets as It Replaces CEO
CVS Health (CVS) stock tumbled about 5% in Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).
CVS ousts Karen Lynch in CEO shakeup
CVS (CVS) has announced that it has replaced its CEO Karen Lynch with longtime executive David Joyner, sending shares sinking in Friday's trading session. Stephanie Davis, Barclays senior research analyst and managing director, joins Market Domination to discuss the leadership shakeup and what it means for CVS moving forward.
Deutsche Bank's George Hill talks CVS shares sinking on CEO shakeup
George Hill, Deutsche Bank managing director, joins 'Closing Bell Overtime' to talk CVS' C-Suite shakeup and what it means for the company.
Events leading up to CVS Health CEO Lynch's departure
CVS Health CEO Karen Lynch is stepping down after nearly four years at the helm, as the healthcare conglomerate faces shareholder pressure to improve its business performance.
CVS ousts CEO amid tanking shares, activist pressure: ‘Brewing for some time'
Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in its large healthcare insurance business and competition for its vast network of retail pharmacies.
CVS Health Stock Slips on C-Suite Shakeup
CVS Health Corp (NYSE:CVS) stock is down 7.3% at $59.04 at last glance, after news that the company has replaced CEO Karen Lynch with pharmacy benefits executive David Joyner.
CVS shakeup: Stock tumbles on abrupt news that David Joyner will replace CEO Karen Lynch
One of the nation's largest healthcare companies is experiencing a seismic shakeup.
CVS Stock Plummets as It Replaces CEO
CVS Health (CVS) stock tumbled about 7% in morning trading Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).
